- Home
- MTRX vs MXCT Comparison
MTRX vs MXCT Comparison
Compare MTRX & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTRX
- MXCT
- Stock Information
- Founded
- MTRX 1984
- MXCT 1999
- Country
- MTRX United States
- MXCT United States
- Employees
- MTRX N/A
- MXCT N/A
- Industry
- MTRX Engineering & Construction
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MTRX Consumer Discretionary
- MXCT Health Care
- Exchange
- MTRX Nasdaq
- MXCT Nasdaq
- Market Cap
- MTRX 327.8M
- MXCT 275.7M
- IPO Year
- MTRX 1990
- MXCT 2021
- Fundamental
- Price
- MTRX $12.58
- MXCT $2.36
- Analyst Decision
- MTRX Strong Buy
- MXCT Strong Buy
- Analyst Count
- MTRX 1
- MXCT 1
- Target Price
- MTRX $20.00
- MXCT $9.00
- AVG Volume (30 Days)
- MTRX 207.2K
- MXCT 743.2K
- Earning Date
- MTRX 05-07-2025
- MXCT 05-07-2025
- Dividend Yield
- MTRX N/A
- MXCT N/A
- EPS Growth
- MTRX N/A
- MXCT N/A
- EPS
- MTRX N/A
- MXCT N/A
- Revenue
- MTRX $742,408,000.00
- MXCT $37,675,000.00
- Revenue This Year
- MTRX $19.64
- MXCT $9.05
- Revenue Next Year
- MTRX $23.51
- MXCT $19.98
- P/E Ratio
- MTRX N/A
- MXCT N/A
- Revenue Growth
- MTRX N/A
- MXCT N/A
- 52 Week Low
- MTRX $8.61
- MXCT $2.21
- 52 Week High
- MTRX $15.75
- MXCT $5.26
- Technical
- Relative Strength Index (RSI)
- MTRX 61.72
- MXCT 33.78
- Support Level
- MTRX $10.01
- MXCT $2.60
- Resistance Level
- MTRX $13.80
- MXCT $2.86
- Average True Range (ATR)
- MTRX 0.90
- MXCT 0.15
- MACD
- MTRX 0.26
- MXCT -0.02
- Stochastic Oscillator
- MTRX 83.03
- MXCT 9.77
About MTRX Matrix Service Company
Matrix Service Co is an engineering and construction provider for large industrial projects, primarily in the oil and gas, power, petrochemical, industrial, mining, and minerals markets. It offers engineering, fabrication, construction, and maintenance services, operating across three segments namely Utility and Power Infrastructure; Process and Industrial Facilities; and Storage and Terminal Solutions.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.